SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP logo
SRRK

SCHOLAR ROCK HOLDING CORP (SRRK)

$7.87--

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$7.27
Day's Range
$8.015
$4.33
52-Week Range
$28.08
1 month return4.95%
3 month return9.23%
1 year return68.81%
5 year return49.23%

Company Information

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock's approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path.
OrganizationSCHOLAR ROCK HOLDING CORP
Employees145
CEOMr. Edward H. Myles M.B.A., MBA
IndustryHealth Technology

Analyst Recommendation

based on 5 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for SCHOLAR ROCK HOLDING CORP(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 186.79%

Current

$7.87

Target

$22.57

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
5
12
12
Hold
0
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
406.6M
Book Value
$5.68
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.03
Wall Street Target Price
22.57

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.39
Enterprise Value
135.1M
Enterprise Value/Revenue
3.63
Enterprise Value/Ebitda
-1.07

Technicals

Beta
0.79
50 Day MA
7.89
200 Day MA
8.96

Institutional Holdings

Artal Group S A

16.94%

T. Rowe Price Associates, Inc.

16.33%

FMR Inc

14.16%

Samsara BioCapital, LLC

8.9%

Redmile Group, LLC

6.59%

Bellevue Group AG

4.17%

Discover more

Frequently Asked Questions

What is SCHOLAR ROCK HOLDING CORP share price today?

Can Indians buy SCHOLAR ROCK HOLDING CORP shares?

How can I buy SCHOLAR ROCK HOLDING CORP shares from India?

Can Fractional shares of SCHOLAR ROCK HOLDING CORP be purchased?

What are the documents required to start investing in SCHOLAR ROCK HOLDING CORP stocks?

What are today’s High and Low prices of SCHOLAR ROCK HOLDING CORP?

What are today’s traded volumes of SCHOLAR ROCK HOLDING CORP?

What is today’s market capitalisation of SCHOLAR ROCK HOLDING CORP?

What is the 52 Week High and Low Range of SCHOLAR ROCK HOLDING CORP?

How much percentage SCHOLAR ROCK HOLDING CORP is down from its 52 Week High?

How much percentage SCHOLAR ROCK HOLDING CORP is up from its 52 Week low?

What are the historical returns of SCHOLAR ROCK HOLDING CORP?

Who is the Chief Executive Officer (CEO) of SCHOLAR ROCK HOLDING CORP?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*